347850.KQ
347850.KQ
KR7347850000
D&D Pharmatech
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 4.297.604.940 11.436.756.600
62.4%
Cost of Revenue -- --
--
Gross Profit 4.297.604.940 11.436.756.600
62.4%
38.290.217.000 36.453.625.000
5.0%
Operating Income -33.992.612.060 -25.016.868.400
35.9%
Pretax Income -24.901.290.210 -30.356.949.530
18.0%
Net Income Common Stockholders -23.554.579.030 -28.622.601.550
17.7%
-- --
--
-- --
--
ende